One day children may get immunized by munching on foods instead of enduring shots. More important,food might save millions who now die for lack of access to traditional inoculants Edible Vaccines by William H.R.Langridge

accines have accomplished near miracles in the fight against infectious disease. They have consigned smallpox to history and should soon Vdo the same for polio. By the late 1990s an international campaign to immunize all the world’s children against six devastating diseases was reportedly reaching 80 per- cent of infants (up from about 5 percent in the mid- 1970s) and was reducing the annual death toll from those infections by roughly three million. Yet these victories mask tragic gaps in delivery. The 20 percent of infants still missed by the six vaccines—against diphtheria, pertussis (whooping cough), polio, measles, tetanus and tuberculosis—account for about two million unnecessary deaths each year, especially in the most re- mote and impoverished parts of the globe. Upheavals in many developing nations now threaten to erode the ad- vances of the recent past, and millions still die from infec- tious diseases for which immunizations are nonexistent, unreliable or too costly. This situation is worrisome not only for the places that lack health care but for the entire world. Regions harbor- ing infections that have faded from other areas are like bombs ready to explode. When environmental or social disasters undermine sanitation systems or displace com- munities—bringing people with little immunity into con- tact with carriers—infections that have been long gone from a population can come roaring back. Further, as in- ternational travel and trade make the earth a smaller place, diseases that arise in one locale are increasingly popping up continents away. Until everyone has routine access to vaccines, no one will be entirely safe. In the early 1990s Charles J. Arntzen, then at Texas A&M University, conceived of a way to solve many of the problems that bar vaccines from reaching all too many children in developing nations. Soon after learning of a World Health Organization call for inexpensive, oral vaccines that needed no refrigeration, Arntzen visit- ed Bangkok, where he saw a mother soothe a crying

FOODS UNDER STUDY as alternatives to injectable vac- cines include bananas, potatoes and tomatoes, as well as

lettuce, rice, wheat, soybeans and corn. JOHNSON & FANCHER

66 Scientific American September 2000 Edible Vaccines Copyright 2000 Scientific American, Inc. BANANA TREES AND growing at the Boyce Thompson Institute for Research at Cornell Uni- versity have been genetically engineered to produce vaccines in their fruit. Bananas are particularly appealing as vaccines be- cause they grow widely in many parts of the developing world, can be eaten raw and are liked by most children.

baby by offering a piece of banana. Plant biologists had al- ready devised ways of introducing selected genes (the blue- prints for proteins) into plants and inducing the altered, or “transgenic,” plants to manufacture the encoded proteins. Perhaps, he mused, food could be genetically engineered to produce vaccines in their edible parts, which could then be eaten when inoculations were needed. The advantages would be enormous. The plants could be grown locally, and cheaply, using the standard growing methods of a given region. Because many food plants can be regenerated readily, the crops could potentially be produced provide lifelong protection; others (such as those for cholera indefinitely without the growers having to purchase more and tetanus) must be readministered periodically. seeds or plants year after year. Homegrown vaccines would Classic vaccines pose a small but troubling risk that the also avoid the logistical and economic problems posed by microorganisms will somehow spring back to life, having to transport traditional preparations over long dis- causing the diseases they were meant to forestall. For that tances, keeping them cold en route and at their destination. reason, vaccine makers today favor so-called subunit prepa- And, being edible, the vaccines would require no syringes— rations, composed primarily of antigenic proteins divorced which, aside from costing something, can lead to infections from a pathogen’s genes. On their own, the proteins have no if they become contaminated. way of establishing an infection. Subunit vaccines, however, Efforts to make Arntzen’s inspired vision a reality are still are expensive, in part because they are produced in cultures quite preliminary. Yet studies carried out in animals over the of bacteria or animal cells and have to be purified out; they past 10 years, and small tests in people, encourage hope that also need to be refrigerated. edible vaccines can work. The research has also fueled spec- Food vaccines are like subunit preparations in that they are ulation that certain food vaccines might help suppress au- engineered to contain but bear no genes that would toimmunity—in which the body’s defenses mistakenly attack enable whole pathogens to form. Ten years ago Arntzen un- normal, uninfected tissues. Among the autoimmune disor- derstood that edible vaccines would therefore be as safe as ders that might be prevented or eased are type I diabetes (the subunit preparations while sidestepping their costs and de- kind that commonly arises during childhood), multiple scle- mands for purification and refrigeration. But before he and rosis and rheumatoid arthritis. others could study the effects of food vaccines in people, they had to obtain positive answers to a number of questions. By Any Other Name … Would plants engineered to carry genes produce functional copies of the specified proteins? When the food egardless of how vaccines for infectious diseases are de- plants were fed to test animals, would the antigens be de- R livered, they all have the same aim: priming the immune graded in the stomach before having a chance to act? (Typi- system to swiftly destroy specific disease-causing agents, or cal subunit vaccines have to be delivered by injection precise- pathogens, before the agents can multiply enough to cause ly because of such degradation.) If the antigens did survive, symptoms. Classically, this priming has been achieved by pre- would they, in fact, attract the immune system’s attention? senting the immune system with whole viruses or bacteria And would the response be strong enough to defend the ani- that have been killed or made too weak to proliferate much. mals against infection? On detecting the presence of a foreign organism in a vac- Additionally, researchers wanted to know whether edible cine, the immune system behaves as if the body were under vaccines would elicit what is known as mucosal immunity. attack by a fully potent antagonist. It mobilizes its various Many pathogens enter the body through the nose, mouth or MULLIN C forces to root out and destroy the apparent invader—target- other openings. Hence, the first defenses they encounter are ing the campaign to specific antigens (proteins recognized as those in the mucous membranes that line the airways, the di- foreign). The acute response soon abates, but it leaves be- gestive tract and the reproductive tract; these membranes HS BY FOREST M

AP hind sentries, known as “memory” cells, that remain on constitute the biggest pathogen-deterring surface in the body. OGR

T alert, ready to unleash whole armies of defenders if the real When the mucosal immune response is effective, it generates HO

P pathogen ever finds its way into the body. Some vaccines molecules known as secretory antibodies that dash into the

Edible Vaccines Scientific American September 2000 67 Copyright 2000 Scientific American, Inc. HOW TO MAKE AN EDIBLE VACCINE

One way of generating edible vaccines relies on the “antigens”—proteins that elicit a targeted immune bacterium Agrobacterium tumefaciens to deliver into response in the recipient.The diagram illustrates the plant cells the genetic blueprints for viral or bacterial production of vaccine potatoes.

BACTERIAL CELL PLANT CELL ANTIGEN GENE DNA PLASMID ANTIBIOTIC- GENE TRANSFER RESISTANCE BACTERIAL GENE SUSPENSION DEAD CELL CALLUS VACCINE POTATOES

ANTIBIOTIC MEDIUM

4 Allow callus to sprout 1 Cut leaf. 2 Expose leaf to bacte- 3 Expose leaf to an anti- shoots and roots. ria carrying an antigen biotic to kill cells that lack gene and an antibiotic- the new genes. Wait for 5 Put in soil. Within three resistance gene.Allow surviving (gene-altered) months,the plantlets will bacteria to deliver the cells to multiply and form grow into plants bearing genes into leaf cells. a clump (callus). antigen-laden vaccine potatoes. JARED SCHNEIDMAN DESIGN cavities of those passageways, neutraliz- tions is yet available to prevent these ills. igenic E. coli, to microbial toxins. Edi- ing any pathogens they find. An effec- By 1995 researchers attempting to an- ble vaccines have also provided laborato- tive reaction also activates a systemic re- swer the many questions before them ry animals with some protection against sponse, in which circulating cells of the had established that plants could indeed challenge by the rabies virus, Helicobac- immune system help to destroy invaders manufacture foreign antigens in their ter pylori (a bacterial cause of ulcers) at distant sites. proper conformations. For instance, and the mink enteric virus (which does Injected vaccines initially bypass mu- Arntzen and his colleagues had intro- not affect humans). cous membranes and typically do a poor duced into tobacco plants the gene for It is not entirely surprising that anti- job of stimulating mucosal immune re- a protein derived from the gens delivered in plant foods survive the sponses. But edible vaccines come into virus and had gotten the plants to syn- trip through the stomach well enough contact with the lining of the digestive thesize the protein. When they injected to reach and activate the immune sys- tract. In theory, then, they would activate the antigen into mice, it activated the tem. The tough outer wall of plant cells both mucosal and systemic immunity. same immune system components that apparently serves as temporary armor That dual effect should, in turn, help im- are activated by the virus itself. (Hep- for the antigens, keeping them relatively prove protection against many danger- atitis B can damage the liver and con- safe from gastric secretions. When the ous microorganisms, including, impor- tribute to liver cancer.) wall finally begins to break up in the in- tantly, the kinds that cause diarrhea. testines, the cells gradually release their Those of us attempting to develop Green Lights on Many Fronts antigenic cargo. food vaccines place a high priority on Of course, the key question is whether combating diarrhea. Together the main ut injection is not the aim; feeding food vaccines can be useful in people. causes—the Norwalk virus, rotavirus, Bis. In the past five years experiments The era of clinical trials for this technol- Vibrio cholerae (the cause of cholera) conducted by Arntzen (who moved to ogy is just beginning. Nevertheless, Arnt- and enterotoxigenic Escherichia coli (a the Boyce Thompson Institute for Plant zen and his collaborators obtained reas- toxin-producing source of “traveler’s Research at Cornell University in 1995) suring results in the first published hu- diarrhea”)—account for some three and his collaborators and by my group man trial, involving about a dozen million infant deaths a year, mainly in at Loma Linda University have demon- subjects. In 1997 volunteers who ate developing nations. These pathogens strated that tomato or plants pieces of peeled, raw potatoes contain- disrupt cells of the small intestine in can synthesize antigens from the Nor- ing a benign segment of the E. coli toxin ways that cause water to flow from the walk virus, enterotoxigenic E. coli, V. (the part called the B subunit) displayed blood and tissues into the intestine. The cholerae and the hepatitis B virus. More- both mucosal and systemic immune re- resulting dehydration may be combated over, feeding antigen-laced tubers or sponses. Since then, the group has also by delivering an intravenous or oral so- fruits to test animals can evoke mucosal seen immune reactivity in 19 of 20 peo- lution of electrolytes, but it often turns and systemic immune responses that ful- ple who ate a potato vaccine aimed at deadly when rehydration therapy is not ly or partly protect animals from subse- the Norwalk virus. Similarly, after Hil- an option. No vaccine practical for quent exposure to the real pathogens or, ary Koprowski of Thomas Jefferson wide distribution in the developing na- in the case of V. cholerae and enterotox- University fed transgenic lettuce carrying

68 Scientific American September 2000 Edible Vaccines Copyright 2000 Scientific American, Inc. a hepatitis B antigen to three volunteers, One targeting strategy involves linking nut-shaped, five-membered ring with a two of the subjects displayed a good sys- antigens to molecules that bind well to hole in the middle. These features raise temic response. Whether edible vaccines immune system components known as the prospect of producing a vaccine can actually protect against human dis- M cells in the intestinal lining. M cells that brings several different antigens to ease remains to be determined, however. take in samples of materials that have M cells at once—thus potentially ful- entered the small intestine (including fulling an urgent need for a single vac- Still to Be Accomplished pathogens) and pass them to other cells cine that can protect against multiple of the immune system, such as antigen- diseases simultaneously. n short, the studies completed so far presenting cells. Macrophages and oth- Researchers are also grappling with Iin animals and people have provided er antigen-presenting cells chop up their the reality that plants sometimes grow a proof of principle; they indicate that acquisitions and display the resulting poorly when they start producing large the strategy is feasible. Yet many issues protein fragments on the cell surface. If amounts of a foreign protein. One solu- must still be addressed. For one, the white blood cells called helper T lym- tion would be to equip plants with reg- amount of vaccine made by a plant is phocytes recognize the fragments as ulatory elements that cause antigen genes low. Production can be increased in dif- foreign, they may induce B lympho- to turn on—that is, give rise to the encod- ferent ways—for instance, by linking cytes (B cells) to secrete neutralizing an- ed antigens—only at selected times (such antigen genes with regulatory elements tibodies and may also help initiate a as after a plant is nearly fully grown or known to help switch on the genes more broader attack on the perceived enemy. is exposed to some outside activator mol- readily. As researchers solve that chal- It turns out that an innocuous seg- ecule) or only in its edible regions. This lenge, they will also have to ensure that ment of the V. cholerae toxin—the B work is progressing. any given amount of a vaccine food pro- subunit—binds readily to a molecule on Further, each type of plant poses its vides a predictable dose of antigen. M cells that ushers foreign material into own challenges. Potatoes are ideal in Additionally, workers could try to en- those cells. By fusing antigens from oth- many ways because they can be propa- hance the odds that antigens will activate er pathogens to this subunit, it should gated from “eyes” and can be stored for the immune system instead of passing be possible to improve the uptake of long periods without refrigeration. But out of the body unused. General stimula- antigens by M cells and to enhance im- potatoes usually have to be cooked to be tors (adjuvants) and better targeting to mune responses to the added antigens. palatable, and heating can denature pro- the immune system might compensate in The B subunit also tends to associate teins. Indeed, as is true of tobacco plants, part for low antigen production. with copies of itself, forming a dough- potatoes were not initially intended to be

VACCINE POTATO HOW EDIBLE VACCINES PROVIDE PROTECTION

An antigen in a food vaccine gets taken up by M infectious agent, not just part of one. That re- cells in the intestine (below, left) and passed to sponse leaves long-lasting “memory” cells able various immune-system cells,which then launch to promptly neutralize the real infectious agent a defensive attack—as if the antigen were a true if it attempts an invasion (right).

ANTIGEN FROM ARRIVING VACCINE VIRUS 3 Antibodies quickly INFECTED ANTIBODY neutralize M CELL CELL the invader

B CELL 1 M cells pass 4 Activated MEMORY the antigen to B cells make B CELL and release macrophages STIMULATORY and B cells antibodies 2 Memory SECRETIONS able to helper T cells MACROPHAGE 3 T cells neutralize CYTOTOXIC swiftly stimulate stimulate the antigen T CELL antibody secretion 2 Macrophages B cells and display HELPER seek out 1 Memory MEMORY pieces of T CELL antigens at helper T cells HELPER the antigen distant sites prod cytotoxic T CELL to helper T cells to attack T cells infected cells

INITIAL RESPONSE WHEN A DISEASE AGENT APPEARS JARED SCHNEIDMAN DESIGN

Edible Vaccines Scientific American September 2000 69 Copyright 2000 Scientific American, Inc. used as vaccine vehicles; they were stud- Bananas need no cooking and are lem. Among the other foods under con- ied because they were easy to manipu- grown widely in developing nations, but sideration are lettuce, carrots, peanuts, late. Surprisingly, though, some kinds of banana trees take a few years to mature, rice, wheat, corn and soybeans. potatoes are actually eaten raw in South and the fruit spoils fairly rapidly after In another concern, scientists need to America. Also, contrary to expectations, ripening. Tomatoes grow more quickly be sure that vaccines meant to enhance cooking of potatoes does not always de- and are cultivated broadly, but they too immune responses do not backfire and stroy the full complement of antigen. So may rot readily. Inexpensive methods suppress immunity instead. Research potatoes may have more practical merit of preserving these foods—such as dry- into a phenomenon called oral tolerance than most of us expected. ing—might overcome the spoilage prob- has shown that ingesting certain pro- teins can at times cause the body to shut down its responses to those proteins. To determine safe, effective doses and feed- Moving against Malnutrition ing schedules for edible vaccines, manu- facturers will need to gain a better han- s research into edible vaccines is progressing,so too are efforts to make foods dle on the manipulations that influence A more nutritious.A much publicized example,“golden rice,”takes aim at vita- whether an orally delivered antigen will min A deficiency, rampant in many parts of Asia, Africa and Latin America. This stimulate or depress immunity. condition can lead to blindness and to immune impairment,which contributes to A final issue worth studying is whether the death of more than a million children each year. food vaccines ingested by mothers can Rice would be a convenient way to deliver the needed vitamin, because the indirectly vaccinate their babies. In the- grain is a daily staple for a third or more of all people on the earth.But natural va- ory, a mother could eat a banana or two rieties do not supply vitamin A.Golden rice,though,has been genetically altered and thus trigger production of antibod- to make beta-carotene,a pigment the body converts to vitamin A. ies that would travel to her fetus via the A team led by Ingo Potrykus of the Swiss Federal Institute of Technology and placenta or to her infant via breast milk. Peter Beyer of the University of Freiburg in Germany formally reported its creation Nonscientific challenges accompany this past January in Science.In May an agribusiness—Zeneca—bought the rights the technical ones. Not many pharma- and agreed to allow the rice to be donated to facilities that will cross the beta- ceutical manufacturers are eager to sup- carotene trait into rice species popular in impoverished areas and will distribute port research for products targeted pri- the resulting products to farmers at no charge. (Zeneca is hoping to make its marily to markets outside the lucrative money from sales of the improved rice in richer countries,where beta-carotene’s West. International aid organizations and antioxidant properties are likely to have appeal.) some national governments and philan- Golden rice is not yet ready to be commercialized, however. Much testing still thropies are striving to fill the gap, but lies ahead,including analyses of whether the human body can efficiently absorb the effort to develop edible vaccines re- the beta-carotene in the rice.Testing is expected to last at least until 2003. mains underfunded. Meanwhile scientists are trying to enrich In addition, edible vaccines fall under rice with still more beta-carotene,with other the increasingly unpopular rubric of “ge- vitamins and with minerals.At a conference netically modified” plants. Recently a last year Potrykus announced success with British company (Axis Genetics) that iron; more than two billion people world- was supporting studies of edible vaccines wide are iron deficient. failed; one of its leaders lays at least Investigators are attempting to enhance part of the blame on investor worry other foods as well. In June, for instance, a g about companies involved with geneti-

eibur group of British and Japanese investigators r cally engineered foods. I hope, however, reported the creation of a tomato contain- y of F that these vaccines will avoid serious

ersit ing a gene able to supply three times the

niv controversy, because they are intended U usual amount of beta-carotene. Conven- to save lives and would probably be YER tional breeding methods are being used, planted over much less acreage than oth- too, such as in an international project fo- ETER BE er food plants (if they are raised outside cused on increasing the vitamin and miner- of greenhouses at all). Also, as drugs, al content of rice and four other staples— TESY OF P they would be subjected to closer scruti-

OUR wheat,corn,beans and cassava. C Not everyone is thrilled by the recent ge- ny by regulatory bodies. “GOLDEN RICE” contains beta- netic coups.Genetically modified (GM) foods carotene, which adds color as well in general remain controversial.Some oppo- Fighting Autoimmunity as nutrition to the grain. nents contend that malnutrition can be com- bated right now in other ways—say, by con- onsideration of one of the chal- structing supply roads. And they fear that companies will tout the benefits of the Clenges detailed here—the risk of in- new foods to deflect attention from worries over other GM crops, most of which ducing oral tolerance—has recently led (such as plants designed to resist damage from pesticides) offer fewer clear advan- my group and others to pursue edible tages for consumers.High on the list of concerns are risk to the environment and to vaccines as tools for quashing autoim- people.Supporters of the nutritionally improved foods hope,however,that the rice munity. Although oral delivery of anti- won’t be thrown out with the rinse water. —Ricki Rusting,staff writer gens derived from infectious agents of- ten stimulates the immune system, oral delivery of “autoantigens” (proteins de-

70 Scientific American September 2000 Edible Vaccines Copyright 2000 Scientific American, Inc. rived from uninfected tis- sue in a treated individ- STOPPING AUTOIMMUNITY ual) can sometimes sup- INTESTINAL press immune activity—a The autoimmune reaction responsible for type I diabetes CAVITY phenomenon seen fre- arises when the immune system mistakes proteins that are quently in test animals. No AUTO- made by pancreatic beta cells (the insulin producers) for for- ANTIGEN one fully understands the eign invaders.The resulting attack,targeted to the offending M CELL DELIVERED reasons for this difference. proteins, or “autoantigens,” destroys the beta cells (below, IN FOOD Some of the evidence left). Eating small amounts of autoantigens quiets the pro- SUPPRESSOR that ingesting autoanti- cess in diabetic mice, for unclear reasons.The autoantigens T CELL gens, or “self-antigens,” might act in part by switching on “suppressor” cells of the might suppress autoimmu- immune system (inset),which then block the destructive ac- nity comes from studies tivities of their cousins (below,right). Activated of type I diabetes, which suppressor cells STIMULATORY HELPER go to pancreas results from autoimmune SECRETIONS T CELL destruction of the insulin- CYTOTOXIC producing cells (beta cells) T CELL of the pancreas. This de- struction progresses si- lently for a time. Eventu- AUTOANTIGEN ally, though, the loss of B CELL beta cells leads to a dras- NATURAL tic shortage of insulin, a KILLER SUPPRESSIVE hormone needed to help CELL SECRETIONS cells take up sugar from ANTIBODY the blood for energy. The DAMAGED AREA PRESERVED loss results in high blood BETA CELL BETA CELL MACROPHAGE sugar levels. Insulin injec- UNDER ATTACK DESTRUCTIVE tions help to control dia- IN PANCREAS SECRETIONS betes, but they are by no means a cure; diabetics BEFORE TREATMENT AFTER TREATMENT

face an elevated risk of se- JARED SCHNEIDMAN DESIGN vere complications. In the past 15 years, investigators have plant-based diabetes vaccines, such as diseases. But, as is true for infectious dis- identified several beta cell proteins that potatoes containing insulin or GAD eases, investigators are exploring a num- can elicit autoimmunity in people pre- linked to the innocuous B subunit of the ber of promising schemes to overcome disposed to type I diabetes. The main V. cholerae toxin (to enhance uptake of that and other challenges. culprits, however, are insulin and a pro- the antigens by M cells). Feeding of the Edible vaccines for combating au- tein called GAD (glutamic acid decar- vaccines to a mouse strain that becomes toimmunity and infectious diseases have boxylase). Researchers have also made diabetic helped to suppress the immune a long way to go before they will be progress in detecting when diabetes is attack and to prevent or delay the onset ready for large-scale testing in people. . nc I

“brewing.” The next step, then, is to find of high blood sugar. The technical obstacles, though, all seem , ed

ways of stopping the underground pro- Transgenic plants cannot yet produce surmountable. Nothing would be more ued as a estb T y g cess before any symptoms arise. the amounts of self-antigens that would satisfying than to protect the health of onstr To that end, my colleagues and I, as be needed for a viable vaccine against many millions of now defenseless chil- e c echnolo

SA T well as other groups, have developed human diabetes or other autoimmune dren around the globe. al edic tional M a The Author Further Information t or of the N

WILLIAM H. R. LANGRIDGE, a leader in the ef- Oral Immunization with a Recombinant Bacterial Antigen Produced in e those of the author and should not b nmen er t ar Transgenic Plants. Charles J. Arntzen in Science, Vol. 268, No. 5211, pages v fort to develop edible vaccines for infectious and au- or ep toimmune diseases, is professor in the department of 714–716; May 5, 1995. al go biochemistry and at the Center for Molecular Biolo- Immunogenicity in Humans of a Recombinant Bacterial Antigen Deliv- eder gy and Gene Therapy at the Loma Linda University ered in a Transgenic Potato. C. O. Tacket et al. in Nature Medicine, Vol. 4, t of the f School of Medicine. After receiving his Ph.D. in bio- No. 5, pages 607–609; May 1998. tained in this r chemistry from the University of Massachusetts at A Plant-Based Cholera Toxin B Subunit-Insulin Fusion Protein Protects on

Amherst in 1973, he conducted genetic research on against the Development of Autoimmune Diabetes. Takeshi Arakawa, Jie ndings c insect viruses and plants at the Boyce Thompson In- Yu, D. K. Chong, John Hough, Paul C. Engen and William H. R. Langridge in stitute for Plant Research at Cornell University. In Nature Biotechnology, Vol. 16, No. 10, pages 934–938; October 1998. decision or endorsemen 1987 he moved to the Plant Biotechnology Center of Plant-Based Vaccines for Protection against Infectious and Autoim- , y opinions and/or fi olic the University of Alberta in Edmonton, and he mune Diseases. James E. Carter and William H. R. Langridge in Critical Re- , p s joined Loma Linda in 1993. views in Plant Sciences (in press). w osition, he vie T p

Edible Vaccines Scientific American September 2000 71 Copyright 2000 Scientific American, Inc.